173 related articles for article (PubMed ID: 17849359)
1. Substance P and its receptors -- a potential target for novel medicines in malignant brain tumour therapies (mini-review).
Łazarczyk M; Matyja E; Lipkowski A
Folia Neuropathol; 2007; 45(3):99-107. PubMed ID: 17849359
[TBL] [Abstract][Full Text] [Related]
2. Tachykinins and tachykinin receptors in bone.
Goto T; Tanaka T
Microsc Res Tech; 2002 Jul; 58(2):91-7. PubMed ID: 12203708
[TBL] [Abstract][Full Text] [Related]
3. Tachykinin receptors and receptor subtypes.
Patacchini R; Maggi CA
Arch Int Pharmacodyn Ther; 1995; 329(1):161-84. PubMed ID: 7639617
[TBL] [Abstract][Full Text] [Related]
4. The role of tachykinins via NK1 receptors in progression of human gliomas.
Palma C; Maggi CA
Life Sci; 2000; 67(9):985-1001. PubMed ID: 10954033
[TBL] [Abstract][Full Text] [Related]
5. Tachykinins regulate the function of platelets.
Graham GJ; Stevens JM; Page NM; Grant AD; Brain SD; Lowry PJ; Gibbins JM
Blood; 2004 Aug; 104(4):1058-65. PubMed ID: 15130944
[TBL] [Abstract][Full Text] [Related]
6. Tachykinins and tachykinin receptors: structure and activity relationships.
Almeida TA; Rojo J; Nieto PM; Pinto FM; Hernandez M; Martín JD; Candenas ML
Curr Med Chem; 2004 Aug; 11(15):2045-81. PubMed ID: 15279567
[TBL] [Abstract][Full Text] [Related]
7. Characterization of tachykinin receptors in the uterus of the oestrogen-primed rat.
Magraner J; Pinto FM; Anselmi E; Hernandez M; Perez-Afonso R; Martín JD; Advenier C; Candenas ML
Br J Pharmacol; 1998 Jan; 123(2):259-68. PubMed ID: 9489614
[TBL] [Abstract][Full Text] [Related]
8. Characterization of receptors mediating contraction induced by tachykinins in the guinea-pig isolated common bile duct.
Patacchini R; Barthó L; Maggi CA
Br J Pharmacol; 1997 Dec; 122(8):1633-8. PubMed ID: 9422808
[TBL] [Abstract][Full Text] [Related]
9. Tachykinins and their receptors in human malignancies.
Palma C
Curr Drug Targets; 2006 Aug; 7(8):1043-52. PubMed ID: 16918332
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumour activity of tachykinin NK1 receptor antagonists on human glioma U373 MG xenograft.
Palma C; Bigioni M; Irrissuto C; Nardelli F; Maggi CA; Manzini S
Br J Cancer; 2000 Jan; 82(2):480-7. PubMed ID: 10646908
[TBL] [Abstract][Full Text] [Related]
11. The mammalian tachykinin receptors.
Maggi CA
Gen Pharmacol; 1995 Sep; 26(5):911-44. PubMed ID: 7557266
[TBL] [Abstract][Full Text] [Related]
12. Functional and molecular characterization of tachykinins and tachykinin receptors in the mouse uterus.
Patak E; Pinto FM; Story ME; Pintado CO; Fleming A; Page NM; Pennefather JN; Candenas ML
Biol Reprod; 2005 May; 72(5):1125-33. PubMed ID: 15647454
[TBL] [Abstract][Full Text] [Related]
13. Advancing drug therapy for brain tumours: a current review of the pro-inflammatory peptide Substance P and its antagonists as anti-cancer agents.
Mander K; Harford-Wright E; Lewis KM; Vink R
Recent Pat CNS Drug Discov; 2014; 9(2):110-21. PubMed ID: 25386916
[TBL] [Abstract][Full Text] [Related]
14. The tachykinin NK1 receptor in the brain: pharmacology and putative functions.
Saria A
Eur J Pharmacol; 1999 Jun; 375(1-3):51-60. PubMed ID: 10443564
[TBL] [Abstract][Full Text] [Related]
15. Neurokinin-receptor antagonists: pharmacological tools and therapeutic drugs.
Longmore J; Hill RG; Hargreaves RJ
Can J Physiol Pharmacol; 1997 Jun; 75(6):612-21. PubMed ID: 9276138
[TBL] [Abstract][Full Text] [Related]
16. The tachykinergic system as avenues for drug intervention.
Rameshwar P
Recent Pat CNS Drug Discov; 2012 Aug; 7(2):173-80. PubMed ID: 22472024
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiological characterisation of tachykinin receptors in the rat nucleus of the solitary tract and dorsal motor nucleus of the vagus in vitro.
Maubach KA; Jones RS
Br J Pharmacol; 1997 Nov; 122(6):1151-9. PubMed ID: 9401780
[TBL] [Abstract][Full Text] [Related]
18. Tachykinin antagonists and the airways.
Joos GF; Kips JC; Peleman RA; Pauwels RA
Arch Int Pharmacodyn Ther; 1995; 329(1):205-19. PubMed ID: 7543746
[TBL] [Abstract][Full Text] [Related]
19. Tachykinins and tachykinin receptors in the gut, with special reference to NK2 receptors in human.
Lecci A; Capriati A; Altamura M; Maggi CA
Auton Neurosci; 2006 Jun; 126-127():232-49. PubMed ID: 16616700
[TBL] [Abstract][Full Text] [Related]
20. Implication of possible therapies targeted for the tachykinergic system with the biology of neurokinin receptors and emerging related proteins.
Rameshwar P
Recent Pat CNS Drug Discov; 2007 Jan; 2(1):79-84. PubMed ID: 18221219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
